OCT 06, 2022 3:20 PM PDT

Regular Fasting Diminishes Key Markers of Alzheimer's in Mice

WRITTEN BY: Annie Lennon

When fed a fasting-mimicking diet, mice genetically engineered to develop Alzheimer's display fewer signs of the condition. The corresponding research was conducted by researchers at the University of Southern California Leonard Davis School of Gerontology and published in Cell Reports.

The fasting-mimicking diet (FMD) is a low-calorie, low-protein, and low-carbohydrate diet that is high in unsaturated fats. It is designed to affect the body similarly to water-only fasting- when a person does not eat although can drink water freely- while still providing essential nutrients. Previous research has shown that brief and periodic cycles of FMD have beneficial physiological effects in both mice and humans. These effects include a reduced risk of cancer, heart disease, and diabetes. 

In the current study, the researchers set out to see whether an FMD diet could limit the progression of Alzheimer's disease in mice. To do so, they studied two models of mice genetically engineered to develop the illness alongside non-Alzheimer's prone controls. 

The genetically engineered mice were split into two groups and either received an FMD diet or a standard diet alongside controls. Each FMD cycle lasted around 4-5 days, before and after which mice were fed standard diets. Mice typically underwent 2 FMD cycles per month. The researchers conducted several experiments with the mice, ultimately assessing the effects of one FMD cycle up to 30 cycles over 15 months. 

In the end, they found that mice who underwent FMD cycles had decreased levels of amyloid beta and tau protein in their brains- hallmarks of Alzheimer's disease- compared to mice on a standard diet. They also had less brain inflammation compared to genetically engineered mice fed a standard diet. 

Those that underwent FMD also performed significantly better on cognitive tests than genetically-engineered mice on standard diets. The researchers further noted that, at times, they even performed similarly to the control mice, implying that FMD may have the potential to significantly reverse cognitive defects.

The researchers also included data from a Phase 1 clinical trial of the FMD in 40 human patients diagnosed with either Alzheimer's disease or mild cognitive impairment. They noted that while intervention is safe and feasible for these patients, further tests are needed to assess resulting levels of inflammation and cognitive performance.

 

Sources: ScienceDaily, Cell Reports

 

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
OCT 25, 2022
Cannabis Sciences
Increase in Cannabis and Hallucinogen Use in Young People
OCT 25, 2022
Increase in Cannabis and Hallucinogen Use in Young People
Cannabis and hallucinogen use among young people has increased among individuals from 19 to 30 years old. The Monitoring ...
NOV 08, 2022
Health & Medicine
Study Recommends Revisiting Heart Transplant Criteria Candidacy for Cannabis Users
NOV 08, 2022
Study Recommends Revisiting Heart Transplant Criteria Candidacy for Cannabis Users
Researchers from Indiana University School of Medicine analyzed pre- and post-operation consideration and clinicians&rsq ...
NOV 08, 2022
Technology
People say too much screen time is bad for kids. But is it really the problem?
NOV 08, 2022
People say too much screen time is bad for kids. But is it really the problem?
Screen time is a parent’s conundrum. How much screen time is too much? How do I adequately monitor my child’ ...
NOV 08, 2022
Neuroscience
Does Nose-Picking Really Increase Alzheimer's Risk?
NOV 08, 2022
Does Nose-Picking Really Increase Alzheimer's Risk?
Researchers have found that a bacterium that travels via the olfactory nerve from the nose to the brain may lead to Alzh ...
DEC 04, 2022
Microbiology
Can Imbalances in the Gut Microbiome Cause Parkinson's Disease?
DEC 04, 2022
Can Imbalances in the Gut Microbiome Cause Parkinson's Disease?
The importance of the gut microbiome has been demonstrated in recent years, and scientists have linked the microbes in t ...
DEC 05, 2022
Neuroscience
Laser Treatment May Improve Short Term Memory
DEC 05, 2022
Laser Treatment May Improve Short Term Memory
Drugs that effectively treat disorders of the brain are very challenging to develop. In the past few decades, researcher ...
Loading Comments...